Jake Shortt - Publications, H-index & Citations

Back

Jake Shortt

monash health

35H-index

331Paper Count

4.5KCitation Count

Published Papers 85

Publication Date

The true cost of red cell transfusion for patients with myelodysplastic syndromes: A time-driven activity-based costing study

British Journal of Haematology

IF3.8

2026-05-21

OAAI

Allison Mo; Helen Haysom; Alayna Carrandi; Sara Carrillo de Albornoz; Jessica Guglielmino; Kylie Rushford; Amanda Ellison; Dan Andrew; Angelene Jesurajah; Erin Hu; Philomina Banahene; Loo Sin Hoo; Alisa M. Higgins; Jake Shortt; Erica M. Wood; Zoe K. McQuilten

Save

Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat for essential thrombocythemia

Blood Advances

IF7.1

2026-03-03

OAAI

Harinder Gill; Francesca Palandri; David M. Ross; Joachim R. Göthert; Tara Cochrane; Stephen R. Larsen; Anna B. Halpern; Jake Shortt; James M. Rossetti; James Liang; Monia Marchetti; Andrew J. Wilson; Andrew J. Innes; Merit Hanna; Nicola Vianelli; William S. Stevenson; Alessandro M. Vannucchi; Maria Kleppe; Jessica Flynn; Georges Natsoulis

Save

Impact of ASXL1 at diagnosis in CML patients receiving frontline potent TKIs: high risk of kinase domain mutations

Blood

IF23.1

2025-09-04

PREAI

Naranie Shanmuganathan; David T. Yeung; Carol Wadham; Adelina Fernandes; Muneeza Maqsood; NurHezrin Shahrin; Verity Saunders; Rosalie R. Kenyon; Ming Lin; John Toubia; Joe McConnell; Dominic Kaczorowski; David M. Ross; Agnes S. M. Yong; Lynette Chee; Jake Shortt; Nicholas Viiala; Jodi Braley; Chung Hoow Kok; Timothy P. Hughes

Save

Red blood cell transfusion practice and cardiac comorbidities in patients with myelodysplastic syndromes

Transfusion

IF2

2025-08-29

OAAI

Allison Mo; Erica M. Wood; Jake Shortt; Zoe K. McQuilten

Save

T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a phase 1 trial

Blood Advances

IF7.1

2025-06-26

OAAI

Eliza A. Hawkes; Jodie B. Palmer; Richard Khor; Sze Ting Lee; Melinda Burgess; Soi C. Law; Maher K. Gandhi; Geoffrey Chong; Jake Shortt; Rakin Chowdhury; Fiona Swain; Leonid Churilov; Michael MacManus; Charmaine Smith; Fiona E. Scott; Arina Martynchyk; Allison Barraclough; Kate Manos; Andrew M. Scott; Colm Keane

Save

Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial

ADVANCES IN THERAPY

IF4

2025-05-16

OAAI

Garcia-Manero, G; Santini, V; Zeidan, AM; Komrokji, RS; Pozharskaya, V; Rose, S; Keeperman, K; Lai, YZ; Kalsekar, S; Aggarwal, B; Miteva, D; Valcarcel, D; Fenaux, P; Shortt, J; Della Porta, MG; Platzbecker, U

Save

Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus

COMMUNICATIONS MEDICINE

IF6.3

2025-04-26

OAAI

Pan, Baolong; Mountford, Simon J.; Kiso, Maki; Anderson, Danielle E.; Papadakis, Georgina; Jarman, Kate E.; Tilmanis, Danielle R.; Maher, Belinda; Tran, Thomas; Shortt, Jake; Yamayoshi, Seiya; Kawaoka, Yoshihiro; Thompson, Philip E.; Greenall, Sam A.; Warner, Nadia

Save

VHL-independent degradation of hepatitis B virus e antigen (HBeAg) by VHL-binding chimeric small molecules

RSC MEDICINAL CHEMISTRY

IF3.6

2025-01-01

PREAI

Hales, Liam T.; Mountford, Simon J.; Takawy, Mina; Colledge, Danni; Maher, Belinda; Shortt, Jake; Greenall, Sam A.; Warner, Nadia

Save

Principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision

SCIENCE ADVANCES

IF12.5

2024-12-20

PREAI

Shembrey, Carolyn; Yang, Ray; Casan, Joshua; Hu, Wenxin; Chen, Honglin; Singh, Gurjeet J.; Sadras, Teresa; Prasad, Krishneel; Shortt, Jake; Johnstone, Ricky W.; Trapani, Joseph A.; Ekert, Paul G.; Fareh, Mohamed

Save

Targeting the Myelodysplasia (MDS) Inflammasome with the Oral Wnt/β-Catenin Pathway Inhibitor, ES-3000 in Combination with Oral Decitabine/Cedazuridine (ASTX727) an Australasian Leukaemia and Lymphoma Group Trial (ALLG MDS05/D1)

BLOOD

IF23.1

2024-11-05

PREAI

Enjeti, Anoop K.; Ramamoorthy, Suthanthirakannan; Hiwase, Devendra; Ashraf, Asma; Butcher, Belinda E.; Kollipara, Sushma; Grove, Carolyn S.; Wei, Andrew H.; Shortt, Jake

Save

Pain crisis complicating severe bone marrow necrosis during induction for acute promyelocytic leukaemia

PATHOLOGY

IF3

2024-11-01

PREAI

Goodall, Elizabeth; Tedjaseputra, Aditya; Hui, Cathryn; Walker, Patricia; Shortt, Jake

Save

Next-generation sequencing RNA fusion panel for the diagnosis of haematological malignancies

PATHOLOGY

IF3

2024-11-01

PREAI

Ngo, Trung Quang; Goh, Anna Fong Na; Dorwal, Pranav; Leong, Emmanuel; Shortt, Jake; Fedele, Pasquale L.; Gilbertson, Michael; Fong, Chun Yew; Shanmuganathan, Naranie; Kumar, Beena; Yeh, Paul

Save

An association between Dasatinib, elevated left atrial pressure and pleural effusion

INTERNATIONAL JOURNAL OF CARDIOLOGY

IF3.2

2024-09-01

PREAI

Tan, Sean; Baggio, Diva; Porch, Kylie; Nerlekar, Nitesh; Shortt, Jake; Ko, Brian

Save

Luspatercept versus epoetin alfa in erythropoiesisstimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial

LANCET HAEMATOLOGY

IF17.7

2024-09-01

PREAI

Porta, Matteo Giovanni Della; Garcia-Manero, Guillermo; Santini, Valeria; Zeidan, Amer M.; Komrokji, Rami S.; Shortt, Jake; Valcarcel, David; Jonasova, Anna; Dimicoli-Salazar, Sophie; Tiong, Ing Soo; Lin, Chien-Chin; Li, Jiahui; Zhang, Jennie; Pilot, Richard; Kreitz, Sandra; Pozharskaya, Veronika; Keeperman, Karen L.; Rose, Shelonitda; Prebet, Thomas; Lai, Yinzhi; Degulys, Andrius; Paolini, Stefania; Cluzeau, Thomas; Fenaux, Pierre; Platzbecker, Uwe

Save

Mapping the IMiD-dependent cereblon interactome using BioID-proximity labelling

FEBS JOURNAL

IF4.2

2024-07-08

OAAI

Costacurta, Matteo; Sandow, Jarrod J.; Maher, Belinda; Susanto, Olivia; Vervoort, Stephin J.; Devlin, Jennifer R.; Garama, Daniel; Condina, Mark R.; Steele, Joel R.; Kahrood, Hossein V.; Gough, Daniel; Johnstone, Ricky W.; Shortt, Jake

Save

Defeating MYC with drug combinations or dual-targeting drugs

TRENDS IN PHARMACOLOGICAL SCIENCES

IF19.9

2024-06-01

PREAI

Thompson, Philip E.; Shortt, Jake

Save

Day-21 bone marrow findings incorrectly designate residual leukaemia in FLT3-mutated acute myeloid leukaemia treated with intensive induction plus midostaurin: a morphology-focused study

PATHOLOGY

IF3

2024-06-01

PREAI

Tedjaseputra, Aditya; Roy, Sukanya; Htun, Kay; Oh, Danielle; Mcquilten, Zoe; Yeh, Paul; Bennett, Ashwini; Low, Michael Sze Yuan; Chunilal, Sanjeev; Wood, Erica M.; Shortt, Jake

Save

How comparable are patient outcomes in the real-world with populations studied in pivotal AML trials?

BLOOD CANCER JOURNAL

IF11.6

2024-03-26

OAAI

Tiong, Ing Soo; Wall, Meaghan; Bajel, Ashish; Kalro, Akash; Fleming, Shaun; Roberts, Andrew W.; Thiagarajah, Nisha; Chua, Chong Chyn; Latimer, Maya; Yeung, David; Marlton, Paula; Johnston, Amanda; Enjeti, Anoop; Fong, Chun Yew; Cull, Gavin; Larsen, Stephen; Kennedy, Glen; Schwarer, Anthony; Kipp, David; Ramanathan, Sundra; Verner, Emma; Tiley, Campbell; Morris, Edward; Hahn, Uwe; Moore, John; Taper, John; Purtill, Duncan; Warburton, Pauline; Stevenson, William; Murphy, Nicholas; Tan, Peter; Beligaswatte, Ashanka; Mutsando, Howard; Hertzberg, Mark; Shortt, Jake; Szabo, Ferenc; Dunne, Karin; Wei, Andrew H.

Save

Mezigdomide and Multiple Myeloma

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2023-09-14

PREAI

Shortt, Jake

Save

Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review

BLOOD REVIEWS

IF5.7

2023-09-01

OAAI

Mo, Allison; Poynton, Matthew; Wood, Erica; Shortt, Jake; Brunskill, Susan J.; Doree, Carolyn; Sandercock, Josie; Saadah, Nicholas; Luk, Edwin; Stanworth, Simon J.; Mcquilten, Zoe

Save

Research Directions